πŸ‡ΊπŸ‡Έ FDA
Patent

US 7820817

Modulators of muscarinic receptors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7820817 (Modulators of muscarinic receptors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/06, A61P17/02